These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 9594163

  • 1. [Monoclonal antibodies against transitional cell carcinoma assay tumor associated antigens in different grades bladder cancer patients].
    Zhang H, Zhao Z, Sun H.
    Zhonghua Wai Ke Za Zhi; 1996 Sep; 34(9):560-2. PubMed ID: 9594163
    [Abstract] [Full Text] [Related]

  • 2. Tumor-associated antigens as prognostic factors for recurrence in 382 patients with primary transitional cell carcinoma of the bladder.
    Allard P, Fradet Y, Têtu B, Bernard P.
    Clin Cancer Res; 1995 Oct; 1(10):1195-202. PubMed ID: 9815912
    [Abstract] [Full Text] [Related]

  • 3. Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium.
    Ben-Aïssa H, Paulie S, Gustafsson B, Håkansson L, Lagerkvist M, Gustafson H, Ahlstrand C, Perlmann P.
    Anticancer Res; 1988 Oct; 8(3):443-9. PubMed ID: 3389746
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Luminal epithelial antigen (LEA.135) expression correlates with tumor progression for transitional carcinoma of the bladder.
    Jones HL, Delahunt B, Bethwaite PB, Thornton A.
    Anticancer Res; 1997 Oct; 17(1B):685-7. PubMed ID: 9066602
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Human transitional cell carcinoma in the NMRI-nu/nu mouse bladder: a new animal model for the in vivo use of monoclonal antibodies and cytotoxic agents.
    Huland E, Arndt R, Huland H.
    Cancer Res; 1986 May; 46(5):2488-9. PubMed ID: 3697989
    [Abstract] [Full Text] [Related]

  • 12. [Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and ABO (H) blood group antigens on tissue sections of urinary bladder tumors].
    Fujioka T, Tanji S, Koike H, Kubo T, Ohhori T.
    Hinyokika Kiyo; 1985 Oct; 31(10):1709-16. PubMed ID: 3911765
    [Abstract] [Full Text] [Related]

  • 13. Human bladder cancer cell-surface antigens recognized by murine monoclonal antibodies raised against T24 bladder cancer cells.
    Masuko T, Abe J, Yagita H, Hashimoto Y.
    Jpn J Cancer Res; 1985 May; 76(5):386-94. PubMed ID: 3924712
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immunohistochemical evaluation of nonspecific cross reactive antigen and carcinoembryonic antigen (CEA) in urinary bladder carcinoma.
    Asamoto M, Fukushima S, Tatemoto Y, Yamada K, Yuba R, Mori M.
    Anticancer Res; 1989 May; 9(2):319-26. PubMed ID: 2751258
    [Abstract] [Full Text] [Related]

  • 17. Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade.
    Kurashige T, Noguchi Y, Saika T, Ono T, Nagata Y, Jungbluth A, Ritter G, Chen YT, Stockert E, Tsushima T, Kumon H, Old LJ, Nakayama E.
    Cancer Res; 2001 Jun 15; 61(12):4671-4. PubMed ID: 11406534
    [Abstract] [Full Text] [Related]

  • 18. [Expression of proliferating cell nuclear antigen in superficial bladder cancer--application to paraffin-embedded tissue sections].
    Wada T, Shimabukuro T, Kurisu H, Shameem IA, Yoshihiro S, Matsuyama H, Naito K, Hashimoto O, Tanaka K.
    Hinyokika Kiyo; 1993 Apr 15; 39(4):313-9. PubMed ID: 8099249
    [Abstract] [Full Text] [Related]

  • 19. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS, Chow NH, Lin JS, Yang WH, Tong YC.
    Anticancer Res; 1998 Apr 15; 18(6B):4717-21. PubMed ID: 9891547
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of HER-2/neu oncogene and transitional cell carcinoma of bladder.
    Jalali Nadoushan MR, Taheri T, Jouian N, Zaeri F.
    Urol J; 2007 Apr 15; 4(3):151-4. PubMed ID: 17987577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.